Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Sermorelin

GHRH (1-29), GRF 1-29 NH2, Sermorelin acetate

Quick Stats
Studies 223
Trials 41
Score 3
1986 pubmed

Clinical experience with GRF.

Ranke. M B MB

Key Findings

  • Synthetic GRF (sermorelin) induces a rapid GH surge up to ~40 ng/mL in healthy adults
  • In children, GH peaks within ~60 minutes; those with GH deficiency show a weaker response
  • Low false‑positive rate indicates potential use as a diagnostic tool for GH deficiency

Practical Outcomes

  • The data validate that a one‑time sermorelin dose can acutely increase GH, which may be useful for short‑term performance or recovery hacks, but it likely won’t overcome a genuine GH deficiency. No dosing schedule or chronic safety info is provided, so any use should be cautious and preferably medically supervised.

Summary

The study shows that a synthetic 29‑amino‑acid version of growth‑hormone‑releasing factor (sermorelin) can quickly raise human growth hormone levels, reaching about 40 ng/mL in healthy volunteers and peaking within an hour in children, though kids with true GH deficiency respond less. It also finds few false‑positive results, suggesting the peptide could help diagnose GH problems. For DIY health enthusiasts, this confirms that a single dose can give a short‑term GH boost, but it won’t fix a real deficiency and long‑term safety isn’t covered.

Abstract

Growth hormone releasing factor (GRF) is one of two main releasing hormones which control pituitary hGH production and release. This activity is retained even when the length of the GRF polypeptide is reduced to the 29 N-terminal residues. This 29-residue polypeptide has been chemically synthesized, and testing in healthy volunteers elicited secretion of hGH to a maximum level of about 40 ng/ml. In a trial of children with various disorders, the maximum hGH response was reached within 60 minutes; those children with hGH deficiency showed much lower responses than those with other disorders not related to hGH deficiency. The frequency of false-positive tests was low, and it is proposed that GRF testing could provide a useful additional tool in the diagnosis of hGH deficiency.

Study Information

Provider

pubmed

Year

1986

Date

1986-04-01T00:00:00.000Z

DOI

10.1111/j.1651-2227.1986.tb10375.x

References

7